News
Drug may still be viable as CMV prophylaxis
Photo by Chad McNeeley HONOLULU—Despite disappointing results in a phase 3 trial, investigators believe the oral nucleotide analog brincidofovir...
News
How an anticancer drug fights lymphoid malignancies
Photo by Cameron Wells, Walter and Eliza Hall Institute of Medical Research Research published in Cell Reports helps explain how the anticancer...
News
Antiplatelet agent approved for long-term use
Photo courtesy of the CDC The European Commission has approved use of the antiplatelet agent ticagrelor (Brilique) at a 60 mg dose to treat...
News
Product approved to treat hemophilia A in EU
The European Commission has approved a full-length recombinant factor VIII product for the treatment and prevention of bleeding in hemophilia A...
News
Teens’ weight, height linked to risk of NHL
A new analysis indicates that having a higher body weight and taller stature during adolescence may increase the risk of developing non-Hodgkin...
News
Factors appear to confer poor survival in AML
receiving chemotherapy Photo by Rhoda Baer A study published in the British Journal of Hematology has revealed factors that appear to affect...
News
Protein ‘map’ could aid development of malaria vaccine
Researchers say they have determined the structure of the protein PvRBP2a, which is used by the malaria parasite Plasmodium vivax to infect human...
News
Drug granted breakthrough designation for AML
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for midostaurin (PKC412) to treat acute myeloid leukemia (...
News
Targeting EZH2 to treat ETP-ALL
The gene EZH2 is a driver of, and potential therapeutic target for, early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), according to a...
News
Risk of reproductive problems in male cancer survivors
A study of Norwegian men has revealed several factors that may help predict reproductive problems among males diagnosed with cancer before age 25...
News
Blood collection set gets FDA clearance, CE mark
Photo by Graham Colm A new blood collection set has received 510(k) clearance from the US Food and Drug Administration as well as the CE mark,...
News
Health Canada approves ruxolitinib for PV
Image courtesy of AFIP Health Canada has approved the JAK1/2 inhibitor ruxolitinib (Jakavi) for the control of hematocrit in adult patients with...
News
FDA aims to protect US blood supply from Zika virus
Photo courtesy of UAB Hospital The US Food and Drug Administration (FDA) has issued a new guidance recommending the deferral of blood donors who...
News
Study: Academic centers fail to report trial results
Photo by Daniel Sone A study published in The BMJ indicates that leading US academic medical centers often fail to report clinical trial results...
News
Pinpointing the cells that cause CML relapse
Image by Difu Wu Preclinical research suggests chronic myeloid leukemia (CML) patients have a heterogeneous population of long-term hematopoietic...